-
More added to the list at various stages either with investigations, layoffs, some trying to figure out how to stay open next year. Some are already deep in debt while some are teetering on the fence post after budget cuts, in short all looking for money to survive and one home health care unit...
-
Called data mining... If you are a researcher and have been accessing the data base from the Broad Institute of MIT and Harvard, that have been hosting such public datasets, they have also removed the aggregate data from public availability. BD NEW YORK (GenomeWeb News) – Large amounts of...
-
New marketing technique going on here, gets you to the website, but no mention of the drug name . This ranks right up there with the Placebo ads from the FDA for a fake blood pressure pill , and what website will it take you to? Is there any honestly or dignity left in advertising? ...
-
In California we are well aware of this with the recent news with Prime Health Care being challenged on this practice as they have no contracts with the insurers and charge their published rates for out of network care, and the patient is stuck in the middle, but from the other side of the coin, some...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
08-29-2008
Filed under:
Filed under: Medically Related, Insurance, My Commentaries, Hospital, health insurance, Physicians, Quest Labs, bankruptcy, Balance Billing, Health Insurance Coverage, Not for Profit Hospitals, Prime Healthcare
-
When you look around, it appears the large Not for Profit folks seems to being doing all the facility expansions, as well as hiring new clinicians, but now some of the practices are being looked at with a bit of scrutiny as the Wall Street Journal discusses. Some facilities charge up to 10 times...
-
Back in June I had posted some information about the use of this technology. Read the source article for more information on how the hospital is sending information to the Social Security Administration, and there is a simple text example on the page to view as well. Nice to have an update...
-
Is this a new sign of the times with the insurers purchasing HMOs? One thing it will do is bring more under contract with additional services and offices available from the consumer end and the employees of the HMO appear to have benefited with keeping their jobs. BD The area's...
-
This process has not be tested on humans yet, but coming soon. The infra red will show the outline of the tumor from a dye injected prior to surgery. The cancer cells literally glow and radiate on a monitor. BD The problem with cancer surgery, or so we hear, is that it's difficult...
-
More money going overseas to help grow a hospital chain and yesterday I had posted about the big medical institutions here having investments overseas, in other words branding facilities with names that are highly accredited here in the US. It appears that more US investors are looking outside...
-
In Forest Hills, New York This hospital just emerged from a 3 year bankruptcy and hopes to have a plan in place before a September 30th deadline closing takes place. BD The State Health Department is reviewing the latest proposal for revamping services at embattled Parkway Hospital in Forest...
-
Is Biotech risky business? I think we can all agree due to the research and development and the unknown areas as far as predicting a winner can be close to a roll of the dice at times. The bar has risen a bit today to secure VC funds no doubt and then we still hear about the failed trials...
-
I have posted this here before, but the $4.00 Generic Resource listings are a good all in one place to find what drugs are offered by the retailers at the discounted price. I appreciate the papers also spreading the word to others. Reuters was the first to circulate and the 2 other...
-
This is another resource that might be helpful with some quick searching capabilities. In this sample, I'm going to use diabetes as a search. A nice word of thanks goes out to Science Roll for putting this together The next section goes to Science Roll's search selection and from...
-
One more new generic coming on to the market for the treatment of Alzheimer's, after FDA approval, which is pending. Patent expires December 2008 but this article states that J and J will appeal ? It sounds like by the time all the red tape is cleared here that it just might be around...
-
A couple months ago, the product was approved by the FDA and is now coming to market. According to the article hospitals and health organizations will be the first visits for marketing and sales, rather than a direct to consumer sale. Intel also has a pretty large interest in biotech related...